Back to News
Market Impact: 0.35
TXG Q3 Earnings Call Highlights Atera Launch and Raised Outlook
Source: zacks.com
Corporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
10x Genomics raised its 2026 revenue outlook, citing strong demand for Atera and growth in spatial consumables. Production constraints and margin pressure remain challenges, tempering the positive outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
TXG0.45
More News
- Tech stock rout, driven by US AI fears, continues in Asian trading
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- Fox completes its $22B acquisition of Roku
- Elanco Shares Jump After Q3 Beat and Outlook Raise
- Paraguay’s Santiago Pena under arrest, new president Pedro Alliana sworn in
- FIGS Beats Earnings as Demand Outstrips Supply, CEO Trina Spear Says